Frontiers in Toxicology,
Год журнала:
2024,
Номер
6
Опубликована: Июль 25, 2024
Purpose
To
demonstrate
and
evaluate
factors
contributing
to
near-cures
in
patients
with
Gadolinium
Deposition
Disease
(GDD)
undergoing
intravenous
(IV)
DTPA
chelation.
Methods
Patients
who
had
undergone
or
are
currently
chelation
for
GDD
were
included
this
report
based
on
their
medical
records
that
showed
perceived
improvement
was
at
least
80%
back
normal.
A
survey
developed
commonly
reported
by
treated
one
clinic
determine
if
these
‘near-cured’
(pre-MRI
baseline
health)
individuals
possessed
certain
lacked
others.
The
anonymized
emailed
the
principal
treating
physician,
only
investigator
not
blinded
subjects.
This
describes
clinical
documentation
of
patient
status
underlying
primary
author,
no
research
performed.
sent
sixteen
individuals;
Fourteen
completed
it
(10
females;
41.1
±
11.2
y/o).
Results
most
common
factor
administration
≤5
lifetime
doses
a
Gadolinium-Based
Contrast
Agents
(GBCA)
(12/14).
Unconfounded
agents
triggering
seen
nine
Most
subjects
(12/14)
initiated
first
year
after
causative
GBCA,
(11/14)
underwent
≤10
chelations
DTPA.
Good
healthcare
prior
MRI
observed
5
majority
described
immune
as
strong.
Severe
physical
disability
1.
Conclusion
Subjects
can
experience
near-cure
IV
Factors
surveyed
predict
include
start
year,
few
GBCA
administrations,
good
health
before
injection.
Nonetheless,
predictors
less
successful
outcomes
still
experienced
near-cure.
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Июнь 15, 2024
Manganese
(Mn)
is
widely
recognized
owing
to
its
low
cost,
non-toxic
nature,
and
versatile
oxidation
states,
leading
the
emergence
of
various
Mn-based
nanomaterials
with
applications
across
diverse
fields,
particularly
in
tumor
diagnosis
therapy.
Systematic
reviews
specifically
addressing
therapy
aspects
Mn-derived
biomaterials
are
lacking.
This
review
comprehensively
explores
physicochemical
characteristics
synthesis
methods
biomaterials,
emphasizing
their
role
diagnostics,
including
magnetic
resonance
imaging,
photoacoustic
photothermal
ultrasound
multimodal
biodetection.
Moreover,
advantages
materials
treatment
discussed,
drug
delivery,
microenvironment
regulation,
synergistic
photothermal,
photodynamic,
chemodynamic
therapies,
immunotherapy,
imaging-guided
The
concludes
by
providing
insights
into
current
landscape
future
directions
for
Mn-driven
advancements
field,
serving
as
a
comprehensive
resource
researchers
clinicians.
World Allergy Organization Journal,
Год журнала:
2024,
Номер
17(9), С. 100946 - 100946
Опубликована: Авг. 20, 2024
Drug
provocation
tests
(DPTs)
are
also
used
in
some
patients
with
a
history
of
contrast
medium
(CM)-hypersensitivity
reaction.
Since
the
use
agents
requires
special
knowledge
that
is
present
radiology
but
not
necessarily
allergology,
this
overview
should
close
gaps.
The
literature,
and
package
inserts
industry
dealing
DPTs
hypersensitivity
reactions
was
analyzed
results
presented.
Historical
analyses
revealed
were
already
done
past,
called
pre-testing.
Due
to
disadvantages,
diagnostic
tool
abandoned.
A
few
years
later,
DPT
introduced
as
an
innovative
procedure.
has
3
main
disadvantages:
missing
standardization,
at
risk
(such
compromised
renal
function)
rarely
taken
into
account,
negative
does
exclude
subsequent
CM
(formerly
pre-testing)
well-known
method
for
diagnosing
CM-related
reactions.
disadvantages
diagnosis
outweigh
advantages,
we
propose
replacing
routine
contrast-enhanced
imaging
examination
radiology.
Journal of Breast Imaging,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 21, 2025
Abstract
Breast
cancer
is
the
most
prevalent
in
women
Europe,
and
while
all
European
countries
have
some
form
of
screening
for
breast
cancer,
disparities
organization
implementation
exist.
density
a
well-established
risk
factor
cancer;
however,
Europe
do
not
recommendations
place
notification
or
additional
supplementary
imaging
with
dense
breasts.
Various
supplemental
modalities
been
investigated
when
comparing
modalities,
MRI
has
shown
to
be
superior
detection
rate
detecting
small
invasive
disease
that
may
impact
long-term
survival,
as
demonstrated
Dense
Tissue
Early
Neoplasm
Screening
(DENSE)
trial
Netherlands.
Based
on
convincing
evidence,
Society
Imaging
issued
category
D
undergo
from
ages
50
70
years
at
least
every
4
preferably
2
3
years.
However,
currently
no
routinely
offer
BI-RADS
breasts
imaging.
The
reasons
lack
are
multifactorial.
Concerns
regarding
increased
recalls
cited,
cost
resources.
studies
cost-effective
compared
current
standard
biannual
mammography.
Furthermore,
abbreviated
protocols
could
facilitate
more
widespread
use
affordable
screening.
Women’s
perception
key
successful
implementation.
Cancers,
Год журнала:
2024,
Номер
16(2), С. 375 - 375
Опубликована: Янв. 16, 2024
Tumor
neoangiogenesis
is
an
important
hallmark
of
cancer
progression,
triggered
by
alternating
selective
pressures
from
the
hypoxic
tumor
microenvironment.
Non-invasive,
non-contrast-enhanced
multiparametric
MRI
combining
blood-oxygen-level-dependent
(BOLD)
MRI,
which
depicts
blood
oxygen
saturation,
and
intravoxel-incoherent-motion
(IVIM)
captures
intravascular
extravascular
diffusion,
can
provide
insights
into
oxygenation
neovascularization
simultaneously.
Our
objective
was
to
identify
imaging
markers
that
predict
hypoxia-induced
angiogenesis
validate
our
findings
using
multiplexed
immunohistochemical
analyses.
We
present
in
vivo
study
involving
36
female
athymic
nude
mice
inoculated
with
luminal
A,
Her2+,
triple-negative
breast
cells.
used
a
high-field
9.4-tesla
system
for
subsequently
analyzed
tumors
multiplex
immunohistochemistry
CD-31,
PDGFR-β,
Hif1-α.
found
hyperoxic-BOLD-MRI-derived
parameter
ΔR2*
discriminated
A
Her2+
cancers,
while
IVIM-derived
fIVIM
cancers.
comprehensive
analysis
principal-component
both
MRI-
mpIHC-derived
data
highlighted
differences
between
conclude
hyperoxic
BOLD
IVIM
without
need
contrast
agents,
offers
promising
non-invasive
evaluating
angiogenesis.
Journal of Neuroimaging,
Год журнала:
2025,
Номер
35(1)
Опубликована: Янв. 1, 2025
ABSTRACT
Background
and
Purpose
The
central
vein
sign
(CVS)
is
a
diagnostic
imaging
biomarker
for
multiple
sclerosis
(MS).
FLAIR*
combined
MRI
contrast
that
provides
high
conspicuity
CVS
at
3
Tesla
(3T),
enabling
its
sensitive
accurate
detection
in
clinical
settings.
This
study
evaluated
whether
of
3T
reliable
across
sites
vendors
gadolinium
(Gd)
increases
conspicuity.
Methods
A
cross‐sectional,
multicenter
recruited
adults
referred
possible
diagnosis
MS
10
sites.
was
generated
using
high‐resolution
T2*‐weighted
(acquired
pre‐
post‐injection
Gd)
T2‐weighted
fluid‐attenuated
inversion
recovery
(T2‐FLAIR)
brain
images
from
two
vendors.
Lesions
veins
were
segmented
to
compute
lesion‐to‐vein
contrast‐to‐noise
ratio
(CNR
),
quantitative
measure
CNR
measures
post‐Gd
compared
Results
Eighty‐seven
participants
nine
included
the
analysis.
There
no
significant
difference
mean
between
pre‐Gd
(
p
‐value
=
0.07)
or
0.27)
FLAIR*.
also
differences
0.10)
0.31)
Patient‐level
pairwise
revealed
increase
<
0.001).
Conclusions
on
consistent
Moreover,
Gd‐based
agent
significantly
improved
These
findings
support
implementation
settings
MS.